Join for free and get access to the buyside
Get insights from the world's most influential hedge fund investors direct to your inbox
- © 2025 Buyside Digest
- Privacy Policy
- Disclaimer
- Sitemap
- Terms of Service
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2025 Q2 | Sep 3, 2025 | McIntyre Partnerships | -2.1% | -18.9% | FTRE, HAYW, LESL, MDRX, SEG, SHC, STHO, SWIM | Concentration, healthcare, small caps, special situations, value, volatility | The fund focuses on small cap value and special situations, specifically targeting off-the-run situations in lesser-followed areas of the market. Small cap special situations significantly underperformed in H1 2025, with median decline of -15% among sub-$5B market cap companies that underwent spinoffs in the last three years. | SEG SHC SEG SHC |
View |
| 2024 Q1 | May 31, 2024 | McIntyre Partnerships | 14.7% | 6.0% | CC, GTX, KRO, MDRX, OSW, SHC, SPHR, TROX, UMG, WMG | Concentration, Cyclical, Opportunistic, small caps, value | The fund is positioned for a cyclical recovery in the TiO2 market after a prolonged downcycle. CC's TiO2 segment EBITDA declined from $809MM in 2021 to $290MM in 2023, but peers are showing strong results with improving volumes and pricing. The manager estimates CC can earn $1.5B in 2025 EBITDA. | CC |
View |
| 2025 Q1 | May 13, 2025 | McIntyre Partnerships | -17.1% | -17.1% | BWA, FTRE, GTX, HAYW, LESL, MDRX, SEG, SHC, STE, STHO, SWIM | Concentration, Healthcare Software, small caps, special situations, value | The fund focuses on concentrated special situations that are often complex, with a benchmark of Russell 2000 Value. The manager emphasizes idiosyncratic ideas with strong catalysts that should be less at the whims of macro forces over time. | MDRX |
View |
| 2026 Q1 | May 11, 2026 | McIntyre Partnerships | -19.8% | -19.8% | CC, FTRE, ICLR, MDRX, QDEL, SEG, SHC, STHO, SWIM | Concentration, Diagnostics, healthcare, Life Sciences, Medical Devices, small cap, value | QDEL |
View | |
| 2024 Q4 | Feb 3, 2025 | McIntyre Partnerships | -5.6% | 0.0% | CC, GTX, HAYW, LESL, MDRX, OSW, SAFE, SEG, SHC, SPHR, STHO, SWIM | Automotive, Concentration, Cyclical, Litigation, real estate, small cap, value | Pool market at cyclical lows similar to Great Financial Crisis with pool starts at 6% of single-family home starts versus historical 11% average. Pool construction highly correlated with residential construction and R&R spending which shows early signs of recovery. | STHO GTX SHC |
View |
| 2025 Q4 | Feb 19, 2026 | McIntyre Partnerships | 0.0% | 6.0% | MDRX, SAFE, SHC, STE | healthcare, liquidation, real estate, small cap, undervalued, value | Portfolio positioned in undervalued securities trading at significant discounts to intrinsic value. Manager emphasizes rotation from winners to laggards where fundamentals are improving but share prices declined. Focus on companies with strong cash generation trading below fair value multiples. Significant exposure to healthcare through sterilization services (SHC) and healthcare software (MDRX). Healthcare IT viewed as defensive with regulatory complexity creating barriers to disruption. Sterilization services seen as recession-proof with predictable growth. Exposure through liquidating real estate holdings (STHO) and entertainment real estate (SEG). Focus on asset monetization and development projects with major tenants like Meow Wolf driving traffic and rental income growth. | MDRX SEG STHO SHC |
View |
| 2024 Q3 | Nov 20, 2024 | McIntyre Partnerships | 14.7% | 6.0% | CC, GTX, HHH, LESL, MDRX, OSW, SEG, SHC, SPHR, STHO | Concentration, real estate, small caps, spinoffs, value | Manager discusses SEG as a bad bank spin from Howard Hughes Holdings, where troubled assets are spun off creating indiscriminate selling and bargain valuations. The spin dynamics created selling pressure from HHH shareholders who lacked mandate for smaller companies. | SEG |
View |
| 2023 Q4 | Jan 19, 2024 | Mott Capital Management | - | 26.7% | AAPL, AMZN, BA, GOOGL, ISRG, MA, MDRX, MSFT, SHOP, SPLK, V | Cash, Fed, growth, rates, technology, Valuations | The composite focuses on thematic growth investing with a long-term approach, owning mega-cap growth names like Apple, Microsoft, Alphabet, and Amazon. The strategy has benefited from the rally in mega-cap growth stocks in 2023. | View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | Fund Letters | McIntyre Partnerships | Veradigm | Health Care | Health Care Technology | Bull | NASDAQ | Delisted, Ehr, FCF yield, Financial Restatement, healthcare software, M&A Target, turnaround, Value | View Pitch |
| Feb 26, 2026 | Fund Letters | Chris McIntyre | Veradigm Inc. | Health Care | Health Care Technology | Bull | NASDAQ | Ehr, FCF, Relisting, SaaS, turnaround | View Pitch |
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| No investor data available. | ||||||||